{"parse":{"title":"EQ-5D","pageid":46461872,"revid":829776342,"text":{"*":"<div class=\"mw-parser-output\"><p><b>EQ-5D</b> is a standardized instrument for measuring generic health status. The health status measured with EQ-5D is used for estimating preference weight for that health status, then by combining the weight with time, <a href=\"/wiki/Quality_Adjusted_Life_Years\" class=\"mw-redirect\" title=\"Quality Adjusted Life Years\">quality-adjusted life year (QALY)</a> can be computed. QALYs gained is used as an outcome in <a href=\"/wiki/Cost-Utility_Analysis\" class=\"mw-redirect\" title=\"Cost-Utility Analysis\">cost-utility analysis</a> which is a type of <a href=\"/wiki/Economic_evaluation\" title=\"Economic evaluation\">economic evaluation</a> that compares the benefit and cost of health care programs or interventions.<sup id=\"cite_ref-:3_1-0\" class=\"reference\"><a href=\"#cite_note-:3-1\">&#91;1&#93;</a></sup> Many countries generated a value set (preference weights) of their own population and have used it for estimating QALY to make decisions in resource allocation.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> There are currently 171 language versions of EQ-5D questionnaire available.<sup id=\"cite_ref-:2_3-0\" class=\"reference\"><a href=\"#cite_note-:2-3\">&#91;3&#93;</a></sup> EQ-5D is one of the most commonly used generic health status measurement, and its good validity and reliability have been reported in various health conditions.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Development\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Development</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Components\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Components</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Descriptive_system\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Descriptive system</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-4\"><a href=\"#EQ-5D-3L\"><span class=\"tocnumber\">2.1.1</span> <span class=\"toctext\">EQ-5D-3L</span></a></li>\n<li class=\"toclevel-3 tocsection-5\"><a href=\"#EQ-5D-Y\"><span class=\"tocnumber\">2.1.2</span> <span class=\"toctext\">EQ-5D-Y</span></a></li>\n<li class=\"toclevel-3 tocsection-6\"><a href=\"#EQ-5D-5L\"><span class=\"tocnumber\">2.1.3</span> <span class=\"toctext\">EQ-5D-5L</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Visual_analogue_scale_(EQ-VAS)\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Visual analogue scale (EQ-VAS)</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Valuation_process\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Valuation process</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Development\">Development</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=1\" title=\"Edit section: Development\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>EQ-5D was first introduced in 1990 by the EuroQol Group.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> This group was initially formed in 1987 with the researchers of multidisciplinary areas from five European countries; Netherlands, UK, Sweden, Finland, and Norway.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> They worked cooperatively with the aim of developing an instrument which is not specific to disease but standardized and can be used as a complement for existing <a href=\"/wiki/Quality_of_life_(healthcare)\" title=\"Quality of life (healthcare)\">health-related quality of life</a> (HRQoL) measures.<sup id=\"cite_ref-:0_6-0\" class=\"reference\"><a href=\"#cite_note-:0-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:4_7-0\" class=\"reference\"><a href=\"#cite_note-:4-7\">&#91;7&#93;</a></sup> Other required characteristics of the new instrument were capable of being sent as a postal questionnaire for self-completion, easy to complete, applicable to everyone, can produce a single index value, and can take into account the health status \u2018worse than dead\u2019.<sup id=\"cite_ref-:4_7-1\" class=\"reference\"><a href=\"#cite_note-:4-7\">&#91;7&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Components\">Components</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=2\" title=\"Edit section: Components\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The EQ-5D questionnaire is made up for two components; health state description and evaluation.<sup id=\"cite_ref-:3_1-1\" class=\"reference\"><a href=\"#cite_note-:3-1\">&#91;1&#93;</a></sup>\n</p><p>In description part, health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Mobility dimension asks about the person's walking ability. Self-care dimension asks about the ability to wash or dress by oneself, and usual activities dimension measures performance in \"work, study, housework, family or leisure activities\". In pain/discomfort dimension, it asks how much pain or discomfort they have, and in anxiety/depression dimension, it asks how anxious or depressed they are. The respondents self-rate their level of severity for each dimension using three-level (EQ-5D-3L) or five-level (EQ-5D-5L) scale.\n</p><p>In evaluation part, the respondents evaluate their overall health status using the <a href=\"/wiki/Visual_analogue_scale\" title=\"Visual analogue scale\">visual analogue scale</a> (EQ-VAS).\n</p>\n<h3><span class=\"mw-headline\" id=\"Descriptive_system\">Descriptive system</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=3\" title=\"Edit section: Descriptive system\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<h4><span class=\"mw-headline\" id=\"EQ-5D-3L\">EQ-5D-3L</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=4\" title=\"Edit section: EQ-5D-3L\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>When EQ-5D was first developed, the scale used in the health state description part was three-level; having no problems, having some or moderate problems, being unable to do/having extreme problems. As an example, three levels of mobility dimension are phrased as \"I have no problems in walking about\", \"I have some problems in walking about\", and \"I am confined to bed\". The respondents are asked to choose one of the statements which best describes their health status of surveyed day. Rated level can be coded as a number 1, 2, or 3, which indicates having no problems for 1, having some problems for 2, and having extreme problems for 3. As a result, a person's health status can be defined by a 5-digit number, ranging from 11111 (having no problems in all dimensions) to 33333 (having extreme problems in all dimensions). 12321 indicates having no problems in mobility and anxiety/depression, having slight problems in self-care and pain/discomfort, and having extreme problems in usual activities. There are potentially 243 (=3<sup>5</sup>) different health states.<sup id=\"cite_ref-:3_1-2\" class=\"reference\"><a href=\"#cite_note-:3-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-:0_6-1\" class=\"reference\"><a href=\"#cite_note-:0-6\">&#91;6&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"EQ-5D-Y\">EQ-5D-Y</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=5\" title=\"Edit section: EQ-5D-Y\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>A 'youth version' of the EQ-5D-3L descriptive system was developed for self-completion by children and younger people.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> It includes equivalent dimensions to the original EQ-5D-3L, phrased so as to be more easily understood and relevant for younger people. The dimensions are: 'mobility', 'looking after myself', 'doing usual activities', 'having pain or discomfort' and 'feeling worried, sad or unhappy'.\n</p>\n<h4><span class=\"mw-headline\" id=\"EQ-5D-5L\">EQ-5D-5L</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=6\" title=\"Edit section: EQ-5D-5L\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Although its brevity contributed a lot for the wide use of EQ-5D, the three-level scale showed some limitations. The major drawback is that it has much fewer descriptive capability of health status compared to other generic instruments. For example, the <a href=\"/wiki/Health_Utilities_Index\" title=\"Health Utilities Index\">Health Utilities Index</a> Mark 2 and Mark 3 (HUI 2 and HUI 3) and the Short Form 6D (SF-6D) can define 24,000, 972,000, and 18,000 unique health states, while EQ-5D-3L can do only 243.<sup id=\"cite_ref-:3_1-3\" class=\"reference\"><a href=\"#cite_note-:3-1\">&#91;1&#93;</a></sup> As a consequence, it suffers from ceiling and flowing effect and showed low sensitivity to catch small changes of health status especially when used to patients with milder conditions.<sup id=\"cite_ref-:2_3-1\" class=\"reference\"><a href=\"#cite_note-:2-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-:1_9-0\" class=\"reference\"><a href=\"#cite_note-:1-9\">&#91;9&#93;</a></sup> To improve such constraints of the three-level scale, the new version of EQ-5D with five-level scale was developed (EQ-5D-5L).<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup> The number of levels of severity was increased to five in this new version; having no problems, having slight problems, having moderate problems, having severe problems and being unable to do/having extreme problems. The new version can define 3,125 (=5<sup>5</sup>) different health states. Some of the wordings of the scale were revisited to be clearer and the instruction for EQ-VAS was simplified. No changes were made for the five dimensions.<sup id=\"cite_ref-:2_3-2\" class=\"reference\"><a href=\"#cite_note-:2-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-:1_9-1\" class=\"reference\"><a href=\"#cite_note-:1-9\">&#91;9&#93;</a></sup>\n</p><p>The validity and reliability of the EQ-5D have been assessed for the different language versions and various health conditions, including cancer, type 2 diabetes, COPD, asthma, and cardiovascular disease, and so on.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> The 5L system showed improved responsiveness compared to the 3L system, and also good validity and reliability . EQ-5D-5L has also been recommended to the elderly population as a generic health status measurement, in combination with other supplementary measurements to capture all related aspects in their quality-of-life.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p>\n<h3><span id=\"Visual_analogue_scale_.28EQ-VAS.29\"></span><span class=\"mw-headline\" id=\"Visual_analogue_scale_(EQ-VAS)\">Visual analogue scale (EQ-VAS)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=7\" title=\"Edit section: Visual analogue scale (EQ-VAS)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Visual analogue scale is the second part of the questionnaire, asking to mark health status on the day of the interview on a 20&#160;cm vertical scale with end points of 0 and 100. There are notes at the both ends of the scale that the bottom rate (0) corresponds to \" the worst health you can imagine\", and the highest rate (100) corresponds to \"the best health you can imagine\".  In the EQ-5D-3L version, the respondents has to draw a line from the box on the questionnaire to the scale indicates the health state of the interviewed day, while the EQ-5D-5L version asks to mark X on the scale to indicate the today's health and write the number of the scale marked in the empty box on the questionnaire.<sup id=\"cite_ref-:2_3-3\" class=\"reference\"><a href=\"#cite_note-:2-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-:0_6-2\" class=\"reference\"><a href=\"#cite_note-:0-6\">&#91;6&#93;</a></sup> A well-known limitation of visual analogue scale is end-of-scale bias that respondents are less likely to use the extreme ends of the scale for rating their health status. However, it is still useful and the simplest direct method for valuing health-related quality of life (HRQoL) weights.<sup id=\"cite_ref-:5_13-0\" class=\"reference\"><a href=\"#cite_note-:5-13\">&#91;13&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Valuation_process\">Valuation process</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=8\" title=\"Edit section: Valuation process\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Once the health status is assessed from the description part, the 5-digit number can be converted into a preference weight which is also referred to as a single weighted index score. It can be done by using methods for generating HRQoL weights, such as visual analogue scale (VAS), the <a href=\"/wiki/Time-trade-off\" title=\"Time-trade-off\">time-trade-off</a> (TTO), and the standard gamble (SG). The choice of the valuation methods can vary. The initial purpose of having visual analogue scale in the EQ-5D questionnaire was to get preference weights using the scale, but the time-trade-off has become favored because it is a \"choice task\", not a \"rating task\" which easily involves some scaling bias.<sup id=\"cite_ref-:5_13-1\" class=\"reference\"><a href=\"#cite_note-:5-13\">&#91;13&#93;</a></sup> Time-trade-off is recommended when performing cost-utility analysis using quality-adjusted life year (QALY) as an outcome, but other methods could be chosen for different type of analyses. A value set was developed using time-trade-off in many countries, including the United Kingdom, United States, Spain, Japan, and Germany.<sup id=\"cite_ref-:4_7-2\" class=\"reference\"><a href=\"#cite_note-:4-7\">&#91;7&#93;</a></sup> The index score of a value set derived from the general population sample can be regarded as a \"<i>societal</i> valuation of the respondent's health state\" in that country. In contrast, the scores from the visual analogue scale in the questionnaire indicates the respondent's <i>own</i> assessment of his/her health status\".<sup id=\"cite_ref-:3_1-4\" class=\"reference\"><a href=\"#cite_note-:3-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> A value set derived from the general population sample has been criticized for a lack of a compelling theoretical support.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=EQ-5D&amp;action=edit&amp;section=9\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-:3-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:3_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:3_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:3_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:3_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:3_1-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Whynes, David K.; TOMBOLA Group (2008-01-01). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2588564\">\"Correspondence between EQ-5D health state classifications and EQ VAS scores\"</a>. <i>Health and Quality of Life Outcomes</i>. <b>6</b>: 94. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/1477-7525-6-94\">10.1186/1477-7525-6-94</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1477-7525\">1477-7525</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2588564\">2588564</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18992139\">18992139</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Health+and+Quality+of+Life+Outcomes&amp;rft.atitle=Correspondence+between+EQ-5D+health+state+classifications+and+EQ+VAS+scores&amp;rft.volume=6&amp;rft.pages=94&amp;rft.date=2008-01-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2588564&amp;rft.issn=1477-7525&amp;rft_id=info%3Apmid%2F18992139&amp;rft_id=info%3Adoi%2F10.1186%2F1477-7525-6-94&amp;rft.aulast=Whynes&amp;rft.aufirst=David+K.&amp;rft.au=TOMBOLA+Group&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2588564&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shaw, James W.; Johnson, Jeffrey A.; Coons, Stephen Joel (2005-03-01). \"US valuation of the EQ-5D health states: development and testing of the D1 valuation model\". <i>Medical Care</i>. <b>43</b> (3): 203\u2013220. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/00005650-200503000-00003\">10.1097/00005650-200503000-00003</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0025-7079\">0025-7079</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15725977\">15725977</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+Care&amp;rft.atitle=US+valuation+of+the+EQ-5D+health+states%3A+development+and+testing+of+the+D1+valuation+model&amp;rft.volume=43&amp;rft.issue=3&amp;rft.pages=203-220&amp;rft.date=2005-03-01&amp;rft.issn=0025-7079&amp;rft_id=info%3Apmid%2F15725977&amp;rft_id=info%3Adoi%2F10.1097%2F00005650-200503000-00003&amp;rft.aulast=Shaw&amp;rft.aufirst=James+W.&amp;rft.au=Johnson%2C+Jeffrey+A.&amp;rft.au=Coons%2C+Stephen+Joel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:2-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:2_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:2_3-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Reenen, Mandy van (April 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L_UserGuide_2015.pdf\">\"EQ-5D-5L User Guide\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>EQ-5D</i>. EuroQol Research Foundation<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 February</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EQ-5D&amp;rft.atitle=EQ-5D-5L+User+Guide&amp;rft.date=2015-04&amp;rft.aulast=Reenen&amp;rft.aufirst=Mandy+van&amp;rft_id=https%3A%2F%2Feuroqol.org%2Fwp-content%2Fuploads%2F2016%2F09%2FEQ-5D-5L_UserGuide_2015.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">EuroQol Group (1990-12-01). \"EuroQol--a new facility for the measurement of health-related quality of life\". <i>Health Policy (Amsterdam, Netherlands)</i>. <b>16</b> (3): 199\u2013208. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0168-8510%2890%2990421-9\">10.1016/0168-8510(90)90421-9</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0168-8510\">0168-8510</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10109801\">10109801</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Health+Policy+%28Amsterdam%2C+Netherlands%29&amp;rft.atitle=EuroQol--a+new+facility+for+the+measurement+of+health-related+quality+of+life&amp;rft.volume=16&amp;rft.issue=3&amp;rft.pages=199-208&amp;rft.date=1990-12-01&amp;rft.issn=0168-8510&amp;rft_id=info%3Apmid%2F10109801&amp;rft_id=info%3Adoi%2F10.1016%2F0168-8510%2890%2990421-9&amp;rft.au=EuroQol+Group&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Brooks, Richard (December 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.euroqol.org/about-eq-5d/working-paper-series/file/EuroQol_Working_Paper_Series_Manuscript_15003_-_Richard_Brooks_01.pdf.html\">\"28 Years of the EuroQol Group: An Overview\"</a>. <i>EQ-5D</i>. EuroQol Research Foundation<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 February</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EQ-5D&amp;rft.atitle=28+Years+of+the+EuroQol+Group%3A+An+Overview&amp;rft.date=2015-12&amp;rft.aulast=Brooks&amp;rft.aufirst=Richard&amp;rft_id=http%3A%2F%2Fwww.euroqol.org%2Fabout-eq-5d%2Fworking-paper-series%2Ffile%2FEuroQol_Working_Paper_Series_Manuscript_15003_-_Richard_Brooks_01.pdf.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:0_6-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Reenen, Mandy van (April 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/EQ-5D-3L_UserGuide_2015.pdf\">\"EQ-5D-3L User Guide\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>EQ-5D</i>. EuroQol Research Foundation<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">22 February</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EQ-5D&amp;rft.atitle=EQ-5D-3L+User+Guide&amp;rft.date=2015-04&amp;rft.aulast=Reenen&amp;rft.aufirst=Mandy+van&amp;rft_id=http%3A%2F%2Fwww.euroqol.org%2Ffileadmin%2Fuser_upload%2FDocumenten%2FPDF%2FFolders_Flyers%2FEQ-5D-3L_UserGuide_2015.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:4-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:4_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:4_7-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:4_7-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rabin, R.; de Charro, F. (2001-07-01). \"EQ-5D: a measure of health status from the EuroQol Group\". <i>Annals of Medicine</i>. <b>33</b> (5): 337\u2013343. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/07853890109002087\">10.3109/07853890109002087</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0785-3890\">0785-3890</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11491192\">11491192</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Medicine&amp;rft.atitle=EQ-5D%3A+a+measure+of+health+status+from+the+EuroQol+Group&amp;rft.volume=33&amp;rft.issue=5&amp;rft.pages=337-343&amp;rft.date=2001-07-01&amp;rft.issn=0785-3890&amp;rft_id=info%3Apmid%2F11491192&amp;rft_id=info%3Adoi%2F10.3109%2F07853890109002087&amp;rft.aulast=Rabin&amp;rft.aufirst=R.&amp;rft.au=de+Charro%2C+F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wille, Nora; Badia, Xavier; Bonsel, Gouke; Burstr\u00f6m, Kristina; Cavrini, Gulia; Devlin, Nancy; Egmar, Ann-Charlotte; Greiner, Wolfgang; Gusi, Narcis (2010-04-20). <a rel=\"nofollow\" class=\"external text\" href=\"https://link.springer.com/article/10.1007/s11136-010-9648-y\">\"Development of the EQ-5D-Y: a child-friendly version of the EQ-5D\"</a>. <i>Quality of Life Research</i>. <b>19</b> (6): 875\u2013886. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11136-010-9648-y\">10.1007/s11136-010-9648-y</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/0962-9343\">0962-9343</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Quality+of+Life+Research&amp;rft.atitle=Development+of+the+EQ-5D-Y%3A+a+child-friendly+version+of+the+EQ-5D&amp;rft.volume=19&amp;rft.issue=6&amp;rft.pages=875-886&amp;rft.date=2010-04-20&amp;rft_id=info%3Adoi%2F10.1007%2Fs11136-010-9648-y&amp;rft.issn=0962-9343&amp;rft.aulast=Wille&amp;rft.aufirst=Nora&amp;rft.au=Badia%2C+Xavier&amp;rft.au=Bonsel%2C+Gouke&amp;rft.au=Burstr%C3%B6m%2C+Kristina&amp;rft.au=Cavrini%2C+Gulia&amp;rft.au=Devlin%2C+Nancy&amp;rft.au=Egmar%2C+Ann-Charlotte&amp;rft.au=Greiner%2C+Wolfgang&amp;rft.au=Gusi%2C+Narcis&amp;rft_id=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs11136-010-9648-y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:1-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Herdman, M.; Gudex, C.; Lloyd, A.; Janssen, Mf; Kind, P.; Parkin, D.; Bonsel, G.; Badia, X. (2011-12-01). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3220807\">\"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)\"</a>. <i>Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation</i>. <b>20</b> (10): 1727\u20131736. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s11136-011-9903-x\">10.1007/s11136-011-9903-x</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1573-2649\">1573-2649</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3220807\">3220807</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21479777\">21479777</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Quality+of+Life+Research%3A+An+International+Journal+of+Quality+of+Life+Aspects+of+Treatment%2C+Care+and+Rehabilitation&amp;rft.atitle=Development+and+preliminary+testing+of+the+new+five-level+version+of+EQ-5D+%28EQ-5D-5L%29&amp;rft.volume=20&amp;rft.issue=10&amp;rft.pages=1727-1736&amp;rft.date=2011-12-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3220807&amp;rft.issn=1573-2649&amp;rft_id=info%3Apmid%2F21479777&amp;rft_id=info%3Adoi%2F10.1007%2Fs11136-011-9903-x&amp;rft.aulast=Herdman&amp;rft.aufirst=M.&amp;rft.au=Gudex%2C+C.&amp;rft.au=Lloyd%2C+A.&amp;rft.au=Janssen%2C+Mf&amp;rft.au=Kind%2C+P.&amp;rft.au=Parkin%2C+D.&amp;rft.au=Bonsel%2C+G.&amp;rft.au=Badia%2C+X.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3220807&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Products/Sample_UK__English__EQ-5D-5L_Paper_Self_complete_v1.0__ID_24700_.pdf\">http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Products/Sample_UK__English__EQ-5D-5L_Paper_Self_complete_v1.0__ID_24700_.pdf</a></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">van Hout, Ben; Janssen, M. F.; Feng, You-Shan; Kohlmann, Thomas; Busschbach, Jan; Golicki, Dominik; Lloyd, Andrew; Scalone, Luciana; Kind, Paul (2012-08-01). \"Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets\". <i>Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research</i>. <b>15</b> (5): 708\u2013715. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jval.2012.02.008\">10.1016/j.jval.2012.02.008</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1524-4733\">1524-4733</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22867780\">22867780</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Value+in+Health%3A+The+Journal+of+the+International+Society+for+Pharmacoeconomics+and+Outcomes+Research&amp;rft.atitle=Interim+scoring+for+the+EQ-5D-5L%3A+mapping+the+EQ-5D-5L+to+EQ-5D-3L+value+sets&amp;rft.volume=15&amp;rft.issue=5&amp;rft.pages=708-715&amp;rft.date=2012-08-01&amp;rft.issn=1524-4733&amp;rft_id=info%3Apmid%2F22867780&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jval.2012.02.008&amp;rft.aulast=van+Hout&amp;rft.aufirst=Ben&amp;rft.au=Janssen%2C+M.+F.&amp;rft.au=Feng%2C+You-Shan&amp;rft.au=Kohlmann%2C+Thomas&amp;rft.au=Busschbach%2C+Jan&amp;rft.au=Golicki%2C+Dominik&amp;rft.au=Lloyd%2C+Andrew&amp;rft.au=Scalone%2C+Luciana&amp;rft.au=Kind%2C+Paul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bulamu, Norma B.; Kaambwa, Billingsley; Ratcliffe, Julie (2015-11-09). <a rel=\"nofollow\" class=\"external text\" href=\"http://hqlo.biomedcentral.com/articles/10.1186/s12955-015-0372-8\">\"A systematic review of instruments for measuring outcomes in economic evaluation within aged care\"</a>. <i>Health and Quality of Life Outcomes</i>. <b>13</b> (1). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/s12955-015-0372-8\">10.1186/s12955-015-0372-8</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4640110\">4640110</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26553129\">26553129</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Health+and+Quality+of+Life+Outcomes&amp;rft.atitle=A+systematic+review+of+instruments+for+measuring+outcomes+in+economic+evaluation+within+aged+care&amp;rft.volume=13&amp;rft.issue=1&amp;rft.date=2015-11-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4640110&amp;rft_id=info%3Apmid%2F26553129&amp;rft_id=info%3Adoi%2F10.1186%2Fs12955-015-0372-8&amp;rft.aulast=Bulamu&amp;rft.aufirst=Norma+B.&amp;rft.au=Kaambwa%2C+Billingsley&amp;rft.au=Ratcliffe%2C+Julie&amp;rft_id=http%3A%2F%2Fhqlo.biomedcentral.com%2Farticles%2F10.1186%2Fs12955-015-0372-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:5-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:5_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:5_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Whitehead, Sarah J.; Ali, Shehzad (2010-01-01). \"Health outcomes in economic evaluation: the QALY and utilities\". <i>British Medical Bulletin</i>. <b>96</b>: 5\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/bmb/ldq033\">10.1093/bmb/ldq033</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1471-8391\">1471-8391</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21037243\">21037243</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Bulletin&amp;rft.atitle=Health+outcomes+in+economic+evaluation%3A+the+QALY+and+utilities&amp;rft.volume=96&amp;rft.pages=5-21&amp;rft.date=2010-01-01&amp;rft.issn=1471-8391&amp;rft_id=info%3Apmid%2F21037243&amp;rft_id=info%3Adoi%2F10.1093%2Fbmb%2Fldq033&amp;rft.aulast=Whitehead&amp;rft.aufirst=Sarah+J.&amp;rft.au=Ali%2C+Shehzad&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Krabbe, Paul; Weijnen, Tom (2003-01-01).  Brooks, Richard; Rabin, Rosalind; Charro, Frank de, eds. <a rel=\"nofollow\" class=\"external text\" href=\"https://link.springer.com/chapter/10.1007/978-94-017-0233-1_2\"><i>Guidelines for analysing and reporting EQ-5D outcomes</i></a>. Springer Netherlands. pp.&#160;7\u201319. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/978-94-017-0233-1_2\">10.1007/978-94-017-0233-1_2</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9789048162611\" title=\"Special:BookSources/9789048162611\">9789048162611</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Guidelines+for+analysing+and+reporting+EQ-5D+outcomes&amp;rft.pages=7-19&amp;rft.pub=Springer+Netherlands&amp;rft.date=2003-01-01&amp;rft_id=info%3Adoi%2F10.1007%2F978-94-017-0233-1_2&amp;rft.isbn=9789048162611&amp;rft.aulast=Krabbe&amp;rft.aufirst=Paul&amp;rft.au=Weijnen%2C+Tom&amp;rft_id=https%3A%2F%2Flink.springer.com%2Fchapter%2F10.1007%2F978-94-017-0233-1_2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gandjour, Afschin (28 May 2010). \"Theoretical Foundation of Patient v. Population Preferences in Calculating QALYs\". <i>Medical Decision Making</i>. <b>30</b> (4): E57\u2013E63. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/0272989X10370488\">10.1177/0272989X10370488</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20511562\">20511562</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+Decision+Making&amp;rft.atitle=Theoretical+Foundation+of+Patient+v.+Population+Preferences+in+Calculating+QALYs&amp;rft.volume=30&amp;rft.issue=4&amp;rft.pages=E57-E63&amp;rft.date=2010-05-28&amp;rft_id=info%3Adoi%2F10.1177%2F0272989X10370488&amp;rft_id=info%3Apmid%2F20511562&amp;rft.aulast=Gandjour&amp;rft.aufirst=Afschin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEQ-5D\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw1315\nCached time: 20180908100444\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.212 seconds\nReal time usage: 0.234 seconds\nPreprocessor visited node count: 885/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 32517/2097152 bytes\nTemplate argument size: 69/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 25403/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.107/10.000 seconds\nLua memory usage: 3.11 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  174.667      1 Template:Reflist\n100.00%  174.667      1 -total\n 64.96%  113.466     10 Template:Cite_journal\n 12.89%   22.518      3 Template:Cite_web\n  3.12%    5.450      1 Template:Cite_book\n  1.62%    2.831      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:46461872-0!canonical and timestamp 20180908100443 and revision id 829776342\n -->\n</div>"},"langlinks":[{"lang":"de","url":"https://de.wikipedia.org/wiki/EQ-5D","langname":"German","autonym":"Deutsch","*":"EQ-5D"}],"categories":[{"sortkey":"","*":"Health_economics"},{"sortkey":"","*":"Healthcare_quality"},{"sortkey":"","*":"Questionnaire_construction"},{"sortkey":"","*":"Patient_reported_outcome_measures"}],"links":[{"ns":0,"exists":"","*":"Cost-Utility Analysis"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Economic evaluation"},{"ns":0,"exists":"","*":"Health Utilities Index"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Quality Adjusted Life Years"},{"ns":0,"exists":"","*":"Quality of life (healthcare)"},{"ns":0,"exists":"","*":"Time-trade-off"},{"ns":0,"exists":"","*":"Visual analogue scale"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC2588564","//doi.org/10.1186/1477-7525-6-94","//www.worldcat.org/issn/1477-7525","//www.ncbi.nlm.nih.gov/pubmed/18992139","//doi.org/10.1097/00005650-200503000-00003","//www.worldcat.org/issn/0025-7079","//www.ncbi.nlm.nih.gov/pubmed/15725977","https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L_UserGuide_2015.pdf","//doi.org/10.1016/0168-8510(90)90421-9","//www.worldcat.org/issn/0168-8510","//www.ncbi.nlm.nih.gov/pubmed/10109801","http://www.euroqol.org/about-eq-5d/working-paper-series/file/EuroQol_Working_Paper_Series_Manuscript_15003_-_Richard_Brooks_01.pdf.html","http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/EQ-5D-3L_UserGuide_2015.pdf","//doi.org/10.3109/07853890109002087","//www.worldcat.org/issn/0785-3890","//www.ncbi.nlm.nih.gov/pubmed/11491192","https://link.springer.com/article/10.1007/s11136-010-9648-y","//doi.org/10.1007/s11136-010-9648-y","//www.worldcat.org/issn/0962-9343","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3220807","//doi.org/10.1007/s11136-011-9903-x","//www.worldcat.org/issn/1573-2649","//www.ncbi.nlm.nih.gov/pubmed/21479777","//doi.org/10.1016/j.jval.2012.02.008","//www.worldcat.org/issn/1524-4733","//www.ncbi.nlm.nih.gov/pubmed/22867780","http://hqlo.biomedcentral.com/articles/10.1186/s12955-015-0372-8","//doi.org/10.1186/s12955-015-0372-8","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4640110","//www.ncbi.nlm.nih.gov/pubmed/26553129","//doi.org/10.1093/bmb/ldq033","//www.worldcat.org/issn/1471-8391","//www.ncbi.nlm.nih.gov/pubmed/21037243","https://link.springer.com/chapter/10.1007/978-94-017-0233-1_2","//doi.org/10.1007/978-94-017-0233-1_2","//doi.org/10.1177/0272989X10370488","//www.ncbi.nlm.nih.gov/pubmed/20511562","http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Products/Sample_UK__English__EQ-5D-5L_Paper_Self_complete_v1.0__ID_24700_.pdf"],"sections":[{"toclevel":1,"level":"2","line":"Development","number":"1","index":"1","fromtitle":"EQ-5D","byteoffset":1869,"anchor":"Development"},{"toclevel":1,"level":"2","line":"Components","number":"2","index":"2","fromtitle":"EQ-5D","byteoffset":3832,"anchor":"Components"},{"toclevel":2,"level":"3","line":"Descriptive system","number":"2.1","index":"3","fromtitle":"EQ-5D","byteoffset":4775,"anchor":"Descriptive_system"},{"toclevel":3,"level":"4","line":"EQ-5D-3L","number":"2.1.1","index":"4","fromtitle":"EQ-5D","byteoffset":4803,"anchor":"EQ-5D-3L"},{"toclevel":3,"level":"4","line":"EQ-5D-Y","number":"2.1.2","index":"5","fromtitle":"EQ-5D","byteoffset":5928,"anchor":"EQ-5D-Y"},{"toclevel":3,"level":"4","line":"EQ-5D-5L","number":"2.1.3","index":"6","fromtitle":"EQ-5D","byteoffset":6898,"anchor":"EQ-5D-5L"},{"toclevel":2,"level":"3","line":"Visual analogue scale (EQ-VAS)","number":"2.2","index":"7","fromtitle":"EQ-5D","byteoffset":10435,"anchor":"Visual_analogue_scale_(EQ-VAS)"},{"toclevel":1,"level":"2","line":"Valuation process","number":"3","index":"8","fromtitle":"EQ-5D","byteoffset":11789,"anchor":"Valuation_process"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"9","fromtitle":"EQ-5D","byteoffset":13994,"anchor":"References"}],"parsewarnings":[],"displaytitle":"EQ-5D","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q19843151"}]}}